MedTrace Logo

Acceptability of HPV-self Sampling

NCT03137563 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 356

Last updated 2020-12-31

No results posted yet for this study

Summary

This trial aimed at evaluating the acceptability of HPV self-sampling among french women eligible for cervical cancer screening (25 - 65 years old) in the region of Occitanie, in the south of France. Acceptability will be evaluated using an anonymous questionnaire and the main outcome of the study will be the response acceptability " yes " or " no " for HPV self-sampling. Secondary outcome will be analysis of socioeconomic determinants for the acceptability of HPV self-sampling.

These data will help to propose new strategies for cervical cancer screening in France, particularly to taget non-attenting populations

Conditions

Interventions

OTHER

questionnaire

The questionnaire will be distributed and collected by the same investigator in one of the eight centers involved in the study. The investigator will verify the inclusion criteria and the absence of exclusion criteria.

Sponsors & Collaborators

  • Dépistages34 (Montpellier - France)

    collaborator UNKNOWN

  • Adoc11 (Carcassonne - France)

    collaborator UNKNOWN

  • Maison médicale Paul Valéry - Union Languedoc Mutualité - (Montpellier -France)

    collaborator UNKNOWN

  • University Hospital, Montpellier

    lead OTHER

Principal Investigators

  • Nathalie BOULLE, MD, PhD · University Hospital, Montpellier

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-05-15
Primary Completion
2017-07-30
Completion
2019-07-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03137563 on ClinicalTrials.gov